Research Topics
| Richard SmithSummaryAffiliation: University of East Anglia Country: UK Publications
| Collaborators
|
Detail Information
Publications
The discrete-choice willingness-to-pay question format in health economics: should we adopt environmental guidelines?R D Smith
Health Economics Group, School of Health Policy and Practice, University of East Anglia, Norwich, UK
Med Decis Making 20:194-206. 2000..The author reviews these issues in a critical assessment of discrete-choice questions...- Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and managementRichard D Smith
Health Economics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7TJ, UK
Soc Sci Med 63:3113-23. 2006.... - Communicable disease control: a 'Global Public Good' perspectiveRichard Smith
Health Economics, Law and Ethics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
Health Policy Plan 19:271-8. 2004.... - The relationship between reliability and size of willingness-to-pay values: a qualitative insightRichard D Smith
Health Economics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
Health Econ 16:211-6. 2007..At low levels of WTP, values appear to be taken from a 'discretionary account', where expenditure is more volatile. Caveats to this result, and suggestions for future research, are considered in the discussion... - Foreign direct investment and trade in health services: a review of the literatureRichard D Smith
Health Economics, Law and Ethics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7TJ, UK
Soc Sci Med 59:2313-23. 2004.... - Why disclosure of genetic tests for health insurance should be voluntaryRichard Smith
School of Medicine, Health Economics Group, University of East Anglia, Norwich, UK
J Health Serv Res Policy 11:184-6. 2006..We outline why voluntary disclosure is the optimal policy as it creates an incentive for people both to undergo testing and to disclose their result thus reducing the potential for adverse section... - The reliability of willingness to pay for changes in health statusRichard D Smith
Health Economics Group School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
Appl Health Econ Health Policy 3:35-8. 2004..The possible implications for the design and use of WTP studies in healthcare are outlined... - Sensitivity to scale in contingent valuation: the importance of the budget constraintRichard D Smith
Health Economics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
J Health Econ 24:515-29. 2005..The methodological implication for CV studies in health care is outlined... - Can we estimate the 'social' value of a QALY? Four core issues to resolveRichard D Smith
University of East Anglia, UK
Health Policy 74:77-84. 2005.... - Assessing the macroeconomic impact of a healthcare problem: the application of computable general equilibrium analysis to antimicrobial resistanceRichard D Smith
Health Economics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7TJ, UK
J Health Econ 24:1055-75. 2005..This approach is described in detail and its 'added value' demonstrated in the case of AMR... - It's not just what you do, it's the way that you do it: the effect of different payment card formats and survey administration on willingness to pay for health gainRichard D Smith
Health Economics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
Health Econ 15:281-93. 2006..The high-to-low version resulted in significantly higher values than the other versions. Further analyses indicate that the randomly shuffled PC version may produce the most 'valid' values... - Use, option and externality values: are contingent valuation studies in health care mis-specified?Richard D Smith
Health Economics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
Health Econ 16:861-9. 2007..The implications for CV in health (care) are considered... - Measuring the globalization of health services: a possible index of openness of country health sectors to tradeRichard Smith
Health Economics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
Health Econ Policy Law 1:323-42. 2006..One specific aspect of this is the 'openness' of a country's health sector to trade; yet there is little, if anything, currently known about the most appropriate methods to assess openness of the health sector... - The relative sensitivity of willingness-to-pay and time-trade-off to changes in health status: an empirical investigationR D Smith
Health Economics Group, University of East Anglia, Norwich, UK
Health Econ 10:487-97. 2001..These results tentatively suggest, therefore, that WTP seems to be a more sensitive measure of change in health status than TTO... - The role of 'reference goods' in contingent valuation: should we help respondents to 'construct' their willingness to pay?Richard D Smith
Health Economics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
Health Econ 16:1319-32. 2007..The implications for CV research in health care are outlined in the discussion... - Construction of the contingent valuation market in health care: a critical assessmentRichard D Smith
Health Economics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
Health Econ 12:609-28. 2003..Suggestions are made concerning why this may be the case, and how the construction of the contingent market may be improved in future... - Genomics knowledge and equity: a global public goods perspective of the patent systemRichard D Smith
Reader in Health Economics, Health Economics and Ethics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, NR4 7TJ, England
Bull World Health Organ 82:385-9. 2004.... - Antimicrobial resistance: a global responseRichard D Smith
Health Economics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, England
Bull World Health Organ 80:126-33. 2002..Approaches are suggested for securing international collective action for the containment of antimicrobial resistance... - Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trialRichard Holland
Clinical Trials Unit, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7TJ
BMJ 334:1098. 2007..To test whether a drug review and symptom self management and lifestyle advice intervention by community pharmacists could reduce hospital admissions or mortality in heart failure patients... - Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectivenessPaula Wilton
Health Economics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
J Health Serv Res Policy 7:111-7. 2002.... - Does home based medication review keep older people out of hospital? The HOMER randomised controlled trialRichard Holland
School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7TJ
BMJ 330:293. 2005..To determine whether home based medication review by pharmacists affects hospital readmission rates among older people... - Directly observed treatment for multidrug-resistant tuberculosis: an economic evaluation in the United States of America and South AfricaP Wilton
Health Economics Group, School of Health Policy and Practice, University of East Anglia, Norwich, United Kingdom
Int J Tuberc Lung Dis 5:1137-42. 2001.... - Precautionary behavior in response to perceived threat of pandemic influenzaM Zia Sadique
Statistics, Modelling and Bioinformatics Department, Health Protection Agency, London, United Kingdom
Emerg Infect Dis 13:1307-13. 2007..This international survey provides insight into what might be expected during an influenza pandemic... - Contingent valuation in health care: does it matter how the 'good' is described?Richard D Smith
Health Policy Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK
Health Econ 17:607-17. 2008..WTP also differed significantly according to condition 'labels'. Possible implications for CV research are outlined... - Trade and public health: facing the challenges of globalisationRichard D Smith
J Epidemiol Community Health 60:650-1. 2006 - How much will Herceptin really cost?Ann Barrett
Department of Oncology, Norfolk and Norwich University Hospital NHS Trust, Norwich NR4 7UY
BMJ 333:1118-20. 2006 - A macroeconomic approach to evaluating policies to contain antimicrobial resistance: a case study of methicillin-resistant Staphylococcus aureus (MRSA)Richard D Smith
School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
Appl Health Econ Health Policy 5:55-65. 2006..CONCLUSION: The permit system appears to offer the most efficient 'solution' to optimising antimicrobial consumption and, hence, reducing the development of resistance... - Using economic analyses for local priority setting : the population cost-impact approachRichard F Heller
Evidence for Population Health Unit, Division of Epidemiology and Health Sciences, University of Manchester, Manchester, UK
Appl Health Econ Health Policy 5:45-54. 2006..Standard methods of economic analysis may not be suitable for local decision making that is specific to a particular population... - Empirical implications of response acquiescence in discrete-choice contingent valuationRaymond Y T Yeung
Department of Community Medicine, Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong SAR
Health Econ 15:1077-89. 2006..The possible extent of CV design versus analysis in discrete-choice methods therefore warrants further exploration... - How common is the 'prominence effect'? Additional evidence to Whynes et alJudith Covey
Department of Psychology, University of Durham, Stockton on Tees, UK
Health Econ 15:205-10. 2006..A number of reasons are outlined to explain this... - Willingness to pay and size of health benefit: an integrated model to test for 'sensitivity to scale'Raymond Y T Yeung
Department of Community Medicine, Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Health Econ 12:791-6. 2003..Results indicate that once data is properly transformed, WTP becomes 'scale sensitive' and consistent with diminishing marginal utility theory... - Global public goods and healthRichard D Smith
Bull World Health Organ 81:475. 2003 - Paying for statinsNick Raithatha
Health Centre, University of East Anglia, Norwich NR4 7TJ
BMJ 328:400-2. 2004 - Disclosure of genetic tests for health insurance: is it ethical not to?Nick Raithatha
Health Centre, University of East Anglia, Norwich NR4 7TJ, UK
Lancet 363:395-6. 2004 - Assessing quality of life in the elderly: a direct comparison of the EQ-5D and AQoLRichard Holland
School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, NR4 7TJ, UK
Health Econ 13:793-805. 2004..We conclude that the AQoL is probably less well suited to measuring health status in a very elderly population than the EQ-5D... - Identification of a novel mitotic phosphorylation motif associated with protein localization to the mitotic apparatusFeng Yang
Environmental Molecular Sciences Laboratory and Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA
J Cell Sci 120:4060-70. 2007..These results provide evidence for a shared phosphorylation event that regulates localization of crucial proteins during mitosis... - Comparative proteogenomics: combining mass spectrometry and comparative genomics to analyze multiple genomesNitin Gupta
Bioinformatics Program, University of California San Diego, La Jolla, California 92093, USA
Genome Res 18:1133-42. 2008..We therefore argue that complementing DNA sequencing projects by comparative proteogenomics projects can be a viable approach to improve both genomic and proteomic annotations... - Whole proteome analysis of post-translational modifications: applications of mass-spectrometry for proteogenomic annotationNitin Gupta
Bioinformatics Program, University of California San Diego, La Jolla, California 92093, USA
Genome Res 17:1362-77. 2007..This study demonstrates that complementing every genome sequencing project by an MS/MS project would significantly improve both genome and proteome annotations for a reasonable cost... - Proteogenomics: needs and roles to be filled by proteomics in genome annotationCharles Ansong
Biological Sciences Division, Pacific Northwest National Laboratory, P O Box 999 K8 98, Richland, WA 99352, USA
Brief Funct Genomic Proteomic 7:50-62. 2008.... - Use of artificial neural networks for the accurate prediction of peptide liquid chromatography elution times in proteome analysesKonstantinos Petritis
Biological Sciences Division and Environmental and Molecular Laboratory, Pacific Northwest National Laboratory, P.O. Box 999, Richland, Washington 99352, USA
Anal Chem 75:1039-48. 2003..Thus, integration of ANN peptide elution time prediction in the proteomic research will increase both the number of protein identifications and their confidence... - Human Proteinpedia enables sharing of human protein dataSuresh Mathivanan
Nat Biotechnol 26:164-7. 2008 - Solving the problem of antimicrobial resistance: is a global approach necessary?Joanna Coast
Drug Discov Today 8:1-2. 2003 - Phosphopeptide elution times in reversed-phase liquid chromatographyJeongkwon Kim
Environmental Molecular Science Laboratory, MSIN K8 98, Pacific Northwest National Laboratory, P O Box 999, Richland, WA 99352, USA
J Chromatogr A 1172:9-18. 2007..28 and +0.59 min). The predictive capability for the observed RPLC elution time change due to phosphorylation has been suggested, which will aid in assigning confident phosphopeptide identifications and their subsequent confirmation... - Elimination of systematic mass measurement errors in liquid chromatography-mass spectrometry based proteomics using regression models and a priori partial knowledge of the sample contentVladislav A Petyuk
Biological Sciences Division and Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington 99352, USA
Anal Chem 80:693-706. 2008..8-3.7-fold. This new procedure will decrease the false discovery rates for peptide identifications using high-accuracy mass measurements... - Self-reported mental health-related quality of life and mortality in men and women in the European Prospective Investigation into Cancer (EPIC-Norfolk): a prospective population studyPhyo K Myint
Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Psychosom Med 69:410-4. 2007..To explore the relationship between self-reported mental functional health and mortality... - Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancerSusan M Varnum
Pacific Northwest National Laboratory, Richland, WA 99352, USA
Breast Cancer Res Treat 80:87-97. 2003..In summary, this study provides the first characterization of the NAF proteome and identifies several candidate proteins for future studies on breast cancer markers in NAF... - Quantitative proteome analysis of breast cancer cell lines using 18O-labeling and an accurate mass and time tag strategyAnil J Patwardhan
UCSF Comprehensive Cancer Center, University of California, San Francisco, CA, USA
Proteomics 6:2903-15. 2006..Hierarchical clustering of protein abundance ratios revealed that several groups of proteins were differentially expressed between the cancer cell lines... - Development and evaluation of a micro- and nanoscale proteomic sample preparation methodHaixing Wang
Biological Sciences Division, Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington 99352, USA
J Proteome Res 4:2397-403. 2005.... - Comparison of normal and breast cancer cell lines using proteome, genome, and interactome dataAnil J Patwardhan
UCSF Comprehensive Cancer Center, University of California-San Francisco, California 94143-0808, USA
J Proteome Res 4:1952-60. 2005..The resulting integrated dataset revealed several functionally related proteins that are differentially regulated between normal and cancer cell lines... - A rational approach for discovering and validating cancer markers in very small samples using mass spectrometry and ELISA microarraysRichard C Zangar
Pacific Northwest National Laboratory, Richland, WA 99352, USA
Dis Markers 20:135-48. 2004.... - Antimicrobial resistance: cost and containmentJoanna Coast
Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol, BS8 2PR, UK
Expert Rev Anti Infect Ther 1:241-51. 2003.... - Obesity indices and self-reported functional health in men and women in the EPIC-NorfolkPhyo K Myint
Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Obesity (Silver Spring) 14:884-93. 2006..To investigate the association between two indices of obesity, BMI and waist-to-hip ratio (WHR), and self-reported physical and mental functional health... - Modifiable lifestyle behaviors and functional health in the European Prospective Investigation into Cancer (EPIC)-Norfolk population studyPhyo K Myint
Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Prev Med 44:109-16. 2007..To examine the association between modifiable lifestyle behaviors and functional health... - Fruit and vegetable consumption and self-reported functional health in men and women in the European Prospective Investigation into Cancer-Norfolk (EPIC-Norfolk): a population-based cross-sectional studyPhyo K Myint
Department of Public Health and Primary Care, University of Cambridge, UK
Public Health Nutr 10:34-41. 2007..To investigate the association between fruit and vegetable consumption and self-reported physical and mental functional health measured by an anglicised short-form 36-item questionnaire (UK SF-36)... - Home-based medication review in older people: is it cost effective?Margaret Pacini
School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
Pharmacoeconomics 25:171-80. 2007..This study aims to determine the cost effectiveness of home-based medication review in older people... - A 'league table' of contingent valuation results for pharmaceutical interventions: a hard pill to swallow?Tracey H Sach
School of Community Health Sciences, University of Nottingham, University Park, Nottingham, UK
Pharmacoeconomics 25:107-27. 2007....